SponsoredReady To Test Your Patients For KRAS G12C? View A Treatment Option For NSCLC Patients. Discover An FDA-Approved Treatment For Patients With KRAS G12C-Mutated NSCLC.
Sponsored>90% purity verfied, High enzymatic activity, coverd G12C/G12D/G12R/G12A variant protein. For screening and validation of small-molecule inhibitors and PROTACs in vitro